NO20014987L - Substituerte azoler - Google Patents

Substituerte azoler

Info

Publication number: NO20014987L
Authority: NO; Norway
Prior art keywords: substituted azoles; azoles; substituted
Prior art date: 1999-04-14

Application number

NO20014987A

Other languages

English (en)

Other versions

NO20014987D0 (no

Inventor

Laszlo Revesz

Achim Schlapbach

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-14

Filing date

2001-10-12

Publication date

2001-12-14

1999-04-14 Priority claimed from GBGB9908531.8A external-priority patent/GB9908531D0/en

1999-04-14 Priority claimed from GBGB9908532.6A external-priority patent/GB9908532D0/en

2001-10-12 Application filed by Novartis Ag filed Critical Novartis Ag

2001-10-12 Publication of NO20014987D0 publication Critical patent/NO20014987D0/no

2001-12-14 Publication of NO20014987L publication Critical patent/NO20014987L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Dermatology (AREA)
Hematology (AREA)
Pulmonology (AREA)
Neurology (AREA)
Ophthalmology & Optometry (AREA)
Transplantation (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Emergency Medicine (AREA)
Obesity (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Gastroenterology & Hepatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20014987A 1999-04-14 2001-10-12 Substituerte azoler NO20014987L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9908531.8A GB9908531D0 (en)	1999-04-14	1999-04-14	Organic compounds
GBGB9908532.6A GB9908532D0 (en)	1999-04-14	1999-04-14	Organic compounds
PCT/EP2000/003290 WO2000063204A2 (en)	1999-04-14	2000-04-12	Substituted azoles

Publications (2)

Publication Number	Publication Date
NO20014987D0 NO20014987D0 (no)	2001-10-12
NO20014987L true NO20014987L (no)	2001-12-14

Family

ID=26315413

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20014987A NO20014987L (no)	1999-04-14	2001-10-12	Substituerte azoler

Country Status (25)

Country	Link
US (1)	US6579874B2 (no)
EP (1)	EP1224180B1 (no)
JP (1)	JP2003503311A (no)
KR (1)	KR20010108504A (no)
CN (1)	CN1378544A (no)
AR (1)	AR023465A1 (no)
AT (1)	ATE244236T1 (no)
AU (1)	AU4295300A (no)
BR (1)	BR0010598A (no)
CA (1)	CA2370417A1 (no)
CO (1)	CO5170501A1 (no)
CZ (1)	CZ20013696A3 (no)
DE (1)	DE60003709T2 (no)
DK (1)	DK1224180T3 (no)
ES (1)	ES2202114T3 (no)
HU (1)	HUP0302747A2 (no)
IL (1)	IL145836A0 (no)
MX (1)	MXPA01010434A (no)
NO (1)	NO20014987L (no)
PE (1)	PE20010031A1 (no)
PL (1)	PL364789A1 (no)
PT (1)	PT1224180E (no)
SK (1)	SK14562001A3 (no)
TR (1)	TR200102967T2 (no)
WO (1)	WO2000063204A2 (no)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2306671T3 (es)	1999-10-07	2008-11-16	Amgen Inc.	Inhibidores de triazina quinasa.
EP1224185B1 (en) *	1999-10-27	2005-11-30	Novartis AG	Thiazole and imidazo[4,5-b]pyridine compounds and their pharmaceutical use
AU2001237041B9 (en) *	2000-02-17	2005-07-28	Amgen Inc.	Kinase inhibitors
EP1343782B1 (en)	2000-12-21	2009-05-06	SmithKline Beecham Corporation	Pyrimidineamines as angiogenesis modulators
CA2436739A1 (en) *	2000-12-26	2002-07-04	Takeda Chemical Industries, Ltd.	Combination agent
CA2437248A1 (en) *	2001-02-02	2002-08-15	Takeda Chemical Industries, Ltd.	Jnk inhibitor
PL363959A1 (en)	2001-03-09	2004-11-29	Pfizer Products Inc.	Triazolopyridines as anti-inflammatory agents
CA2440211A1 (en)	2001-03-09	2002-09-19	Pfizer Products Inc.	Benzimidazole anti-inflammatory compounds
EP1247810B1 (en)	2001-04-04	2005-09-07	Pfizer Products Inc.	Novel benzotriazoles anti-inflammatory compounds
US20050080113A1 (en) *	2001-06-11	2005-04-14	Shigenori Ohkawa	Medicinal compositions
CA2456606C (en)	2001-09-21	2010-01-26	Solvay Pharmaceuticals B.V.	4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
US7109216B2 (en)	2001-09-21	2006-09-19	Solvay Pharmaceuticals B.V.	1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
TWI231757B (en) *	2001-09-21	2005-05-01	Solvay Pharm Bv	1H-Imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
US7473695B2 (en) *	2001-10-22	2009-01-06	Mitsubishi Tanabe Pharma Corporation	4-imidazolin-2-one compounds
AU2002360621B2 (en) *	2001-12-19	2007-01-25	Merck & Co., Inc.	heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5
AR039241A1 (es) *	2002-04-04	2005-02-16	Biogen Inc	Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos
DE60310730T2 (de)	2002-07-09	2007-05-16	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Pharmazeutische zusammensetzungen aus anticholinergica und p38 kinase hemmern zur behandlung von erkrankungen der atemwege
TW200812986A (en) *	2002-08-09	2008-03-16	Nps Pharma Inc	New compounds
CN1894241A (zh)	2002-08-09	2007-01-10	阿斯利康(瑞典)有限公司	作为代谢型谷氨酸受体－5调节剂的“1,2,4” 噁二唑
US7074809B2 (en)	2002-08-09	2006-07-11	Astrazeneca Ab	Compounds
US7012143B2 (en)	2002-08-30	2006-03-14	Dombroski Mark A	Cycloalkyl-[4-(difluorophenyl)-oxazol-5-yl]-triazolo-pyridines
PA8579601A1 (es)	2002-08-30	2004-05-07	Pfizer Prod Inc	Compuestos antiinflamatorios de di y trifloruro-triazolo-piridinas
US6949652B2 (en)	2002-08-30	2005-09-27	Pfizer, Inc.	Crystalline forms of 3-isopropyl-6-[4-(2,5-difluoro-phenyl)-oxazol-5-yl]-[1,2,4]triazolo-[4,3-A]pyridine
AU2003253188A1 (en) *	2002-08-30	2004-03-19	Pfizer Products Inc.	Novel processes and intermediates for preparing triazolo-pyridines
US7005523B2 (en)	2002-08-30	2006-02-28	Pfizer Inc.	Cycloalkyl-[4-(trifluorophenyl)-oxazol-5yl]-triazolo-pyridines
US7037923B2 (en)	2002-08-30	2006-05-02	Pfizer, Inc.	Alkyl-[4-(trifluorophenyl)-oxazol-5-yl]-triazolo-pyridines
UA80295C2 (en) *	2002-09-06	2007-09-10	Biogen Inc	Pyrazolopyridines and using the same
CA2511521C (en)	2002-12-30	2012-02-07	Angiotech International Ag	Drug delivery from rapid gelling polymer composition
CA2515119A1 (en)	2003-02-07	2004-08-19	Daiichi Pharmaceutical Co., Ltd.	Pyrazole derivative
ES2264795T3 (es)	2003-02-14	2007-01-16	Pfizer Products Inc.	Triazolo-piridinas como compuestos antiinflamatorios.
TWI326282B (en) *	2004-04-28	2010-06-21	Mitsubishi Tanabe Pharma Corp	Heterocyclic compound
CN1980901A (zh) *	2004-06-30	2007-06-13	万有制药株式会社	联芳基衍生物
US20060035893A1 (en)	2004-08-07	2006-02-16	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
PE20060777A1 (es)	2004-12-24	2006-10-06	Boehringer Ingelheim Int	Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
JP5519152B2 (ja) *	2006-02-08	2014-06-11	ザジェネラルホスピタルコーポレイション	光学顕微鏡法を用いて解剖学的サンプルに関わる情報を取得するための装置
ES2301380B1 (es)	2006-08-09	2009-06-08	Laboratorios Almirall S.A.	Nuevos derivados de 1,7-naftiridina.
ES2320955B1 (es)	2007-03-02	2010-03-16	Laboratorios Almirall S.A.	Nuevos derivados de 3-((1,2,4)triazolo(4,3-a)piridin-7-il)benzamida.
ES2329639B1 (es)	2007-04-26	2010-09-23	Laboratorios Almirall S.A.	Nuevos derivados de 4,8-difenilpoliazanaftaleno.
JP2010526781A (ja)	2007-04-30	2010-08-05	アボット・ラボラトリーズ	ジアシルグリセロールｏ−アシル転移酵素１型酵素の阻害剤
EP1992344A1 (en)	2007-05-18	2008-11-19	Institut Curie	P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
US9029411B2 (en)	2008-01-25	2015-05-12	Millennium Pharmaceuticals, Inc.	Thiophenes and uses thereof
EP2108641A1 (en)	2008-04-11	2009-10-14	Laboratorios Almirall, S.A.	New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
EP2113503A1 (en)	2008-04-28	2009-11-04	Laboratorios Almirall, S.A.	New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors
US9090601B2 (en)	2009-01-30	2015-07-28	Millennium Pharmaceuticals, Inc.	Thiazole derivatives
US9139589B2 (en)	2009-01-30	2015-09-22	Millennium Pharmaceuticals, Inc.	Heteroaryls and uses thereof
US8796314B2 (en)	2009-01-30	2014-08-05	Millennium Pharmaceuticals, Inc.	Heteroaryls and uses thereof
KR20120016247A (ko) *	2009-05-19	2012-02-23	다우 아그로사이언시즈 엘엘씨	진균 방제를 위한 화합물 및 방법
EP2322176A1 (en)	2009-11-11	2011-05-18	Almirall, S.A.	New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one derivatives
MA34797B1 (fr)	2010-08-11	2014-01-02	Millennium Pharm Inc	Hétéroaryles et leurs utilisations
US9062038B2 (en)	2010-08-11	2015-06-23	Millennium Pharmaceuticals, Inc.	Heteroaryls and uses thereof
JP2013533318A (ja)	2010-08-11	2013-08-22	ミレニアムファーマシューティカルズ，インコーポレイテッド	ヘテロアリールおよびその使用
PH12013500723A1 (en)	2010-10-13	2017-08-23	Millennium Pharm Inc	Heteroaryls and uses thereof
AR086113A1 (es)	2011-04-30	2013-11-20	Abbott Lab	Isoxazolinas como agentes terapeuticos
WO2017151409A1 (en)	2016-02-29	2017-09-08	University Of Florida Research Foundation, Incorporated	Chemotherapeutic methods
WO2018159650A1 (ja) *	2017-02-28	2018-09-07	東レ株式会社	グアニジン誘導体及びその医薬用途
WO2021138391A1 (en)	2019-12-30	2021-07-08	Tyra Biosciences, Inc.	Indazole compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69433501T2 (de) *	1993-11-08	2004-11-04	Smithkline Beecham Corp.	Oxazole zur behandlung von zytokinvermittelten erkrankungen
US5739143A (en) *	1995-06-07	1998-04-14	Smithkline Beecham Corporation	Imidazole compounds and compositions
US5658903A (en) *	1995-06-07	1997-08-19	Smithkline Beecham Corporation	Imidazole compounds, compositions and use
ES2193256T3 (es) *	1995-08-10	2003-11-01	Merck & Co Inc	Aril pirroles 2-sustituidos, composiciones que contienen tales compuestos y procedimientos de uso.
US6492516B1 (en) *	1999-05-14	2002-12-10	Merck & Co., Inc.	Compounds having cytokine inhibitory activity

2000
- 2000-04-11 CO CO00026470A patent/CO5170501A1/es not_active Application Discontinuation
- 2000-04-12 MX MXPA01010434A patent/MXPA01010434A/es unknown
- 2000-04-12 PE PE2000000337A patent/PE20010031A1/es not_active Application Discontinuation
- 2000-04-12 KR KR1020017013086A patent/KR20010108504A/ko not_active Withdrawn
- 2000-04-12 IL IL14583600A patent/IL145836A0/xx unknown
- 2000-04-12 CZ CZ20013696A patent/CZ20013696A3/cs unknown
- 2000-04-12 WO PCT/EP2000/003290 patent/WO2000063204A2/en not_active Ceased
- 2000-04-12 DE DE60003709T patent/DE60003709T2/de not_active Expired - Fee Related
- 2000-04-12 PT PT00922630T patent/PT1224180E/pt unknown
- 2000-04-12 JP JP2000612294A patent/JP2003503311A/ja active Pending
- 2000-04-12 CN CN00807552A patent/CN1378544A/zh active Pending
- 2000-04-12 DK DK00922630T patent/DK1224180T3/da active
- 2000-04-12 HU HU0302747A patent/HUP0302747A2/hu unknown
- 2000-04-12 AU AU42953/00A patent/AU4295300A/en not_active Abandoned
- 2000-04-12 CA CA002370417A patent/CA2370417A1/en not_active Abandoned
- 2000-04-12 ES ES00922630T patent/ES2202114T3/es not_active Expired - Lifetime
- 2000-04-12 PL PL00364789A patent/PL364789A1/xx not_active Application Discontinuation
- 2000-04-12 SK SK1456-2001A patent/SK14562001A3/sk unknown
- 2000-04-12 BR BR0010598-8A patent/BR0010598A/pt not_active IP Right Cessation
- 2000-04-12 TR TR2001/02967T patent/TR200102967T2/xx unknown
- 2000-04-12 EP EP00922630A patent/EP1224180B1/en not_active Expired - Lifetime
- 2000-04-12 AT AT00922630T patent/ATE244236T1/de not_active IP Right Cessation
- 2000-04-12 AR ARP000101686A patent/AR023465A1/es unknown
2001
- 2001-10-12 US US09/975,913 patent/US6579874B2/en not_active Expired - Fee Related
- 2001-10-12 NO NO20014987A patent/NO20014987L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
KR20010108504A (ko)	2001-12-07
DK1224180T3 (da)	2003-10-20
PL364789A1 (en)	2004-12-13
WO2000063204A3 (en)	2002-05-23
BR0010598A (pt)	2002-02-05
PE20010031A1 (es)	2001-02-23
CN1378544A (zh)	2002-11-06
ES2202114T3 (es)	2004-04-01
CA2370417A1 (en)	2000-10-26
EP1224180A2 (en)	2002-07-24
AU4295300A (en)	2000-11-02
PT1224180E (pt)	2003-11-28
SK14562001A3 (sk)	2002-03-05
DE60003709D1 (de)	2003-08-07
TR200102967T2 (tr)	2002-01-21
MXPA01010434A (es)	2002-03-27
WO2000063204A2 (en)	2000-10-26
CO5170501A1 (es)	2002-06-27
EP1224180B1 (en)	2003-07-02
DE60003709T2 (de)	2004-12-23
JP2003503311A (ja)	2003-01-28
ATE244236T1 (de)	2003-07-15
NO20014987D0 (no)	2001-10-12
CZ20013696A3 (cs)	2002-02-13
HUP0302747A2 (hu)	2003-12-29
US20020049220A1 (en)	2002-04-25
US6579874B2 (en)	2003-06-17
AR023465A1 (es)	2002-09-04
IL145836A0 (en)	2002-07-25

Publication	Publication Date	Title
DK1224180T3 (da)	2003-10-20	Substituerede azoler
NO20016115L (no)	2002-02-12	Substituerte heterosykelkondenserte gamma-karbolin
EE200100502A (et)	2002-12-16	Ühendid
DE122007000064I1 (de)	2008-01-03	Erythropoietinkonjugate
EE200300049A (et)	2004-10-15	Imidasooli derivaadid
DE60040714D1 (de)	2008-12-18	Ewährleisten
ATA51899A (de)	2002-04-15	Handstempel
DE60018989D1 (de)	2005-04-28	N-carbamoyloxyalkyl-substituierte azolium-verbindungen
ATE360620T1 (de)	2007-05-15	Imidazolderivate
DK1070708T3 (da)	2004-05-10	Triazolderivater
ATE297895T1 (de)	2005-07-15	4-pyridinyl-n-acyl-l-phenylalanine
NO20013769L (no)	2001-09-26	Kalsilytiske forbindelser
NO20020466L (no)	2002-03-20	Kalsilytiske forbindelser
DE69935205D1 (de)	2007-04-05	Unterbrechungssteurerungssystem
NO20014262D0 (no)	2001-09-03	Tiazoloindolinon-forbindelser
NO20022927D0 (no)	2002-06-18	Substituerte pyrrazoler
DE19983890T1 (de)	2002-03-07	Ventiltaktgebungsjustiereinrichtung
ATE269311T1 (de)	2004-07-15	Benzoylpyridazine
ATA121799A (de)	2002-03-15	Ausbeulgerät
ATE251154T1 (de)	2003-10-15	Substituierte phenyluracile
ID29984A (id)	2001-10-25	Senyawa-senyawa bis-stirilbifenil
FI4295U1 (fi)	2000-01-19	Vieroituslaite
ATA107599A (de)	2002-06-15	Heizwasserbereiter
DE10085167T1 (de)	2002-11-07	Gangumschalteinrichtung
ATA732000A (de)	2004-04-15	Kachelofen

Legal Events

Date	Code	Title	Description
2004-12-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application